TransMedics Ownership
| TMDX Stock | USD 118.80 1.20 1.02% |
Shares in Circulation | First Issued 2018-03-31 | Previous Quarter 32.6 M | Current Value 34.2 M | Avarage Shares Outstanding 24.9 M | Quarterly Volatility 6.5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
TransMedics |
TransMedics Stock Ownership Analysis
About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.77. TransMedics Group had not issued any dividends in recent years. TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company was founded in 1998 and is headquartered in Andover, Massachusetts. Transmedics operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 148 people. To find out more about TransMedics Group contact the company at 978 552 0900 or learn more at https://www.transmedics.com.Besides selling stocks to institutional investors, TransMedics also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different TransMedics' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align TransMedics' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
TransMedics Quarterly Liabilities And Stockholders Equity |
|
TransMedics Insider Trades History
Roughly 3.0% of TransMedics Group are currently held by insiders. Unlike TransMedics' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against TransMedics' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of TransMedics' insider trades
TransMedics Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as TransMedics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading TransMedics Group backward and forwards among themselves. TransMedics' institutional investor refers to the entity that pools money to purchase TransMedics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Goldman Sachs Group Inc | 2023-12-31 | 794.6 K | State Street Corporation | 2023-12-31 | 787.1 K | Sandhill Capital Partners Llc | 2023-12-31 | 763.2 K | First Light Asset Management, Llc | 2023-12-31 | 754.3 K | Allspring Global Investments Holdings, Llc | 2023-12-31 | 708.3 K | Geode Capital Management, Llc | 2023-12-31 | 700.7 K | Bank Of New York Mellon Corp | 2023-12-31 | 687 K | Bellevue Group Ag | 2023-12-31 | 518.9 K | Emerald Advisers, Llc | 2023-12-31 | 516.4 K | Fmr Inc | 2023-12-31 | 4.8 M | Blackrock Inc | 2023-12-31 | 2.6 M |
TransMedics Group Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific TransMedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on TransMedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases TransMedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
TransMedics Corporate Filings
8K | 30th of April 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 18th of April 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 10th of April 2024 Other Reports | ViewVerify | |
10K | 27th of February 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
TransMedics Investors Sentiment
The influence of TransMedics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in TransMedics. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to TransMedics' public news can be used to forecast risks associated with an investment in TransMedics. The trend in average sentiment can be used to explain how an investor holding TransMedics can time the market purely based on public headlines and social activities around TransMedics Group. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TransMedics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TransMedics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average TransMedics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on TransMedics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TransMedics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TransMedics' short interest history, or implied volatility extrapolated from TransMedics options trading.
Currently Active Assets on Macroaxis
When determining whether TransMedics Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TransMedics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Transmedics Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Transmedics Group Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in unemployment. Note that the TransMedics Group information on this page should be used as a complementary analysis to other TransMedics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for TransMedics Stock analysis
When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is TransMedics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TransMedics. If investors know TransMedics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TransMedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.77) | Revenue Per Share 7.431 | Quarterly Revenue Growth 1.587 | Return On Assets 0.0006 | Return On Equity (0.15) |
The market value of TransMedics Group is measured differently than its book value, which is the value of TransMedics that is recorded on the company's balance sheet. Investors also form their own opinion of TransMedics' value that differs from its market value or its book value, called intrinsic value, which is TransMedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TransMedics' market value can be influenced by many factors that don't directly affect TransMedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TransMedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TransMedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TransMedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.